Abstract:<h3 class="Heading">Background</h3><p class="Para">Though the roles of microRNAs (miRNAs) in renal diseases have been extensively investigated, a thorough screening and comparison of miRNAs among different types of chronic kidney disease (CKD) has never been performed.</p><h3 class="Heading">Methods</h3><p class="Para">The intrarenal miRNAs were profiled from fresh kidney tissues of patients with biopsy-proven minimal change disease (MCD), focal segmental glomerular sclerosis (FSGS) and diabetic nephropathy (DN) by using microarray. Commonly dysregulated miRNAs were validated by real-time PCR using paraffin-embedded renal tissues from all three types of CKD patients as well as mouse unilateral ureteral obstruction (UUO) model. Two novel miRNAs were selected and annotations of their target genes were performed using GO and KEGG pathway enrichment analysis. Biological functions of three two candidate miRNAs were explored in TGF-β1-induced cell model using human kidney proximal tubular cells (HK-2).</p><h3 class="Heading">Results</h3><p class="Para">The kidney biopsy samples of three disease types represent different levels of damage and fibrosis, which were the mildest in MCD, moderate in FSGS, and the most severe in DN. 116 miRNAs were identified to be commonly dysregulated, including 40 up-regulated and 76 down-regulated in CKD tissues as compared with healthy donor kidney biopsy tissues. Two novel miRNAs, hsa-miR-3607-3p and hsa-miR-4709-3p, were verified as consistently differentially expressed among all three types of patient samples as well as in mouse model. In vitro, hsa-miR-3607-3p was repressed while hsa-miR-4709-3p was induced by TGF-β1 treatment. Inhibition of hsa-miR-3607-3p or overexpression of hsa-miR-4709-3p promoted TGF-β1-induced migration and F-actin assembling in HK-2 cells, which are characteristics of epithelial–mesenchymal transition (EMT). Further study identified that ITGB8 and CALM3 were the bona fide target genes of hsa-miR-3607-3p and hsa-miR-4709-3p respectively.</p><h3 class="Heading">Conclusions</h3><p class="Para">The present identify a unique miRNAs profile that probably relates to the common fibrosis process of CKD. Results of our study suggest that hsa-miR-3607-3p and hsa-miR-4709-3p may represent as promising therapeutic targets against kidney fibrosis.</p>

Microrna Expression Profiling Of Kidney Tissues In Patients With Congenital Ureteropelvic Junction Obstruction

iTRAQ-based proteomics and in vitro experiments reveals essential roles of ACE and AP-N in the renin–angiotensin system-mediated congenital ureteropelvic junction obstruction

Quantitative Proteome of Infant Stenotic Ureters Reveals Extracellular Matrix Organization and Oxidative Stress Dysregulation Underlying Ureteropelvic Junction Obstruction.

Tissue-Specific Microrna Expression Patterns in Four Types of Kidney Disease

Quantitative Urinary Proteome Reveals Potential Biomarkers for Ureteropelvic Junction Obstruction.

Differentially Expressed Micrornas in Kidney Biopsies from Various Subtypes of Nephrotic Children.

Matrix Remodeling-Associated Protein 5 in Urinary Exosomes as a Potential Novel Marker of Obstructive Nephropathy in Children With Ureteropelvic Junction Obstruction

Network Architecture of Non-Coding RNAs Provides Insights into the Pathogenesis of Upper Tract Urothelial Carcinoma

Semaphorin-3A and Netrin-1 predict the development of kidney injury in children with congenital hydronephrosis

Laboratory-Bladder Cancer Network architecture of non-coding RNAs provides insights into the pathogenesis of upper tract urothelial carcinoma

MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key Mirnas

Detection of miRNA in kidney biopsies of child patients with nephrotic syndrome and its significance

Association between NDUFS1 from urinary extracellular vesicles and decreased differential renal function in children with ureteropelvic junction obstruction

<i>N</i><SUP>6</SUP>-Methyladenosine Methylomic Landscape of Ureteral Deficiency in Reflux Uropathy and Obstructive Uropathy

Predicting clinically significant events in children with ureteropelvic junction obstruction

Gene Expression Profiling of Micrornas Associated with UCA1 in Bladder Cancer Cells.

Clinicopathological Analysis of Congenital Ureteropelvic Junction Obstruction

Intrarenal microRNA signature related to the fibrosis process in chronic kidney disease: identification and functional validation of key miRNAs

Differential Expression Profile of Micrornas in Clear Cell Renal Cell Carcinoma

Reduction in Mirna-125B-5p Levels is Associated with Obstructive Renal Injury

Comprehensive Investigation of Aberrant Microrna Profiling in Bladder Cancer Tissues.